News summary

NAD+ Metabolic Reprogramming Drives CD8+ T Cells Senescence and Exacerbates Ulcerative Colitis

Source: Aging Cell • Published: 10 Sept 2026, 03:30

Summarized by Masters of Longevity from Aging Cell.

NAD+ metabolism and its impact on CD8+ T cell aging — a research article exploring metabolic reprogramming as a contributor to immune senescence and inflammatory disease.

NAD+ Metabolic Reprogramming Drives CD8+ T Cells Senescence and Exacerbates Ulcerative Colitis
Key Takeaways
  • Shifts toward altered NAD+ metabolism in CD8+ T cells drive their senescence and functional decline in disease contexts.
  • Senescent CD8+ T cells with disrupted NAD+ homeostasis contribute to worsened intestinal inflammation in ulcerative colitis models.
  • Restoring NAD+ balance in CD8+ T cells can reduce senescence markers and ameliorate colitis severity in experimental systems.
Read the full article at Aging Cell

Continue exploring

Recommended MoL Picks

MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.